Sort
17,288 grants matching “multiple sclerosis”
A Novel Tolerance Therapeutic for Treating Multiple Sclerosis
$1,000,000Neil A Fanger · Virtici, Llc · R44 · FY2017 · AI
Safe and effective anti CD154 antibodies for therapeutic intervention
$1,000,000Jay L Rothstein · Immunext, Inc. · R44 · FY2015 · AI
UNCOVERING THE RELATIONSHIP BETWEEN MYELIN AND SYNAPSE DYNAMICS IN MULTIPLE SCLEROSIS
$999,999Regents Of The University Of California, San Francisco, The · · FY2025 · Defense Health Agency
CELL-FREE DNA EPIGENETIC BIOMARKERS IN MULTIPLE SCLEROSIS
$999,999Regents Of The University Of California, San Francisco, The · · FY2025 · Defense Health Agency
Alloantigen Delivery Via ECDI-Fixed Cells For Tolerance To Monkey Islet Grafts
$999,893Bernhard Josef Hering · University Of Minnesota · U01 · FY2015 · AI
ELUCIDATING THE BIOLOGICAL MECHANISMS UNDERLYING THE ASSOCIATION BETWEEN EPSTEIN-BARR VIRUS AND MULTIPLE SCLEROSIS
$999,799President And Fellows Of Harvard College · · FY2025 · Defense Health Agency
A Single-cell Platform for Analyzing the Peripheral Immune Response in Alzheimerâs and Alzheimerâs Related Diseases
$999,615Timothy S McConnell · Isoplexis, Inc. · R44 · FY2020 · AG
MAGNETIC RESONANCE IMAGING-GUIDED TRANSCRIPTOMIC ANALYSIS OF SPINAL CORD NEURODEGENERATION AND DEMYELINATION IN MULTIPLE SCLEROSIS
$999,566The Cleveland Clinic Foundation · · FY2025 · Defense Health Agency
Development of a small molecule activator of integrin cell adhesion to enhance therapeutic responses to checkpoint blockade in cancer
$999,501Upendra Marathi · 7 Hills Pharma, Llc · R42 · FY2018 · CA
Jamboxx: Interactive Respiratory Therapy through Music and Gaming
$999,500Michael Dicesare · My Music Machines, Inc. · R42 · FY2017 · HL
IMPACT OF OBESITY-DRIVEN GUT MICROBIOTA ALTERATIONS ON MULTIPLE SCLEROSIS SEVERITY
$999,265The University Of Iowa · · FY2025 · Defense Health Agency
Genetic Architecture of Pure Alzheimer's Disease and Mixed Pathology
$998,897Shubhabrata Mukherjee · University Of Washington · R01 · FY2024 · AG
A Novel Probiotic for the Treatment of Sjogren's Syndrome
$998,658Gary Fanger · Rise Therapeutics, Llc · SB1 · FY2021 · DE
Development of a first-in-class therapeutic for producing 'on-demand' voiding
$998,525Karl B Thor · Dignify Therapeutics, Llc · R44 · FY2019 · DK
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects
$998,210Jeffrey S King · Virogenomics Biodevelopment, Inc. · R44 · FY2020 · AI
DEVELOPMENT OF NEW IMAGING METHODOLOGY TO ASSESS GLIAL CELL-DRIVEN PATHOLOGY IN MULTIPLE SCLEROSIS
$998,176Turun Yliopisto · · FY2024 · Defense Health Agency
A Haplotype Map for Multiple Sclerosis
$997,968Stephen L Hauser · University Of California, San Francisco · R01 · FY2013 · NS
MULTIDIMENSIONAL IMAGING DATA-DRIVEN APPROACH FOR PHENOTYPING MULTIPLE SCLEROSIS
$997,343Cedars-Sinai Medical Center · · FY2025 · Defense Health Agency
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects
$996,926Jeffrey S King · Virogenomics Biodevelopment, Inc. · R44 · FY2021 · AI
Development of DRα1-MOG-35-55 for treatment of DR2 negative MS subjects
$996,486Renee Lynn Shirley · Virogenomics Biodevelopment, Inc. · R44 · FY2022 · AI
NEUROIMAGING ANALYSIS CENTER
$995,566Brigham And Women'S Hospital · P41 · FY2001 · RR
Validation of a Negative Regulator as a Novel Therapy for Autoimmune Disease
$995,160Matthew F. Mackey · Immunext, Inc. · R42 · FY2014 · AI
Development of a Novel, Targeted Small Molecule Inhibitor of the Nucleoside Salvage Pathway to Treat Systemic Lupus Erythematosus
$994,978Kenneth Schultz · Trethera Corporation · R44 · FY2025 · AI
Nervous System Development and Plasticity
$994,606Richard Douglas Fields · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2012 · HD
IMMUNOGENETICS OF DEMYELINATION
$994,535Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2002 · NS